Epilepsy and Cannabis
From a painting in the church at Grottaferrata. Oskar Rosenthal, Published: 1925
Image credit: Wellcome Library, London
In a survey of parents using cannabidiol (CBD)-enriched cannabis as a treatment for children with treatment-resistant epilepsy, a high rate of success in reducing seizure frequency was reported.
Report of a parent survey of cannabidiol-enriched
cannabis use in pediatric treatment-resistant epilepsy.
Porter BE, Jacobson C.
Epilepsy Behav. 2013 Dec;29(3):574-7.
PubMed PMID: 24237632; PubMed Central PMCID: PMC4157067.
A CBD based medicine developed by GW Pharmacueticals is being trialled in the USA.
Epidiolex® has been given orphan drug status by the FDA for Lennox-Gastaut Syndrome.
Press release: 28 February 2014
URL: GW Pharmaceuticals Receives Orphan Drug Designation by FDA for Epidiolex® in the Treatment of Lennox-Gastaut Syndrome. Fast track designation has also been given by the FDA for Dravet Syndrome. GW Pharmaceuticals.
Press release: 6 June 2014
URL: GW Pharmaceuticals Announces Epidiolex® Receives Fast Track Designation from FDA for the Treatment of Dravet Syndrome.
GW Pharmacueticals: Epidiolex
Articles and editorials
The Chronicle - July 2015
Medical cannabis is helping save my son's life